Meeting
2016 ASCO Annual Meeting
Trabectedin for advanced soft-tissue sarcoma: A single-center experience of over 10 years.
Authors
Imran Syed
Sarcoma Oncology Center, Santa Monica, CA
Imran Syed , Madhuri Sudan , William Tseng , Prarthana Parthasarathy , William Esteves Mendanha , Neal Shiv Chawla , Rishi Nanda , Justin Daneshrad , Bryan Leong , Babak Aryanfar , Susan Arasheben , Katherine Kim , Erlinda Maria Gordon , Kamalesh Kumar Sankhala , Sant P. Chawla
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Clinical Trial Registration Number
Multiple clinical trials
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11052)
DOI
10.1200/JCO.2016.34.15_suppl.11052
Abstract #
11052
Poster Bd #
178
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Trabectedin for advanced soft tissue sarcoma: Ten-year real-life perspective.
First Author: Sivan Shamai
Poster
2016 ASCO Annual Meeting
Cardiac safety analysis of trabectedin (T) vs. dacarbazine (D) in patients (Pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior anthracycline chemotherapy.
First Author: Scott Schuetze
Poster
2023 ASCO Annual Meeting
Alternative splicing (AS) regulation as a novel therapeutic target in soft-tissue sarcoma (STS).
First Author: David Silva Moura
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Epidemiology and survival analysis of non-GIST GI sarcomas: A two-decade analysis of SEER database.
First Author: Snigdha Nutalapati